5 powerful seeds that help lower bad cholesterol naturally and the right way to consume them ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

An analysis of 2019 insurance claim data and national survey results shows that the prevalence of digestive diseases in the ...

Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...

New CRC diagnoses increasingly occur before age 65, with incidence rising 3% annually in ages 20–49 and 45% of cases now occurring under 65 years. Distal colon and rectal tumors drive early-onset ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 –– Reduced secured and convertible debt by 90% from ...

The global MedTech market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next five years. This expansion is driven by rising volumes of surgical and ...

Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...

Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.